Drugmakers will think twice on price increases after Trump's Pfizer skirmish, says analyst

2:34 PM ET Mon, 16 July 2018

Elliot Wilbur, Raymond James specialty pharmaceuticals analyst, discusses the rising cost of prescription drugs and how President Trump is tackling the issue.